Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
2026 New York City Broker-Dealer Compliance Fall RoundtableTuesday, September 29, 2026Sidley Elevates Cross-Practice Data Centers and Digital Infrastructure Platform for the Next Phase of Digital Infrastructure InvestmentAugust 25, 2026Sidley Represents Rael in Its Strategic Investment from TowerBrook Capital PartnersAugust 24, 2026Trending Issues in State AI Regulation as Seen Through Connecticut’s Omnibus AI Law (SB5)August 21, 2026Sidley Represents Stone Point Capital in Acquisition of Ever.Ag’s Risk Management BusinessAugust 20, 2026Sidley Represents Ridgeview Partners in Its Proposed £545 Million Acquisition of Pinewood TechnologiesAugust 19, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
